Current Curcumin Studies
By Dr. Joseph Mercola | September 13, 2021
Curcumin is the major biologically active polyphenolic compound of turmeric and gives the spice its yellow color. Recent research shows the biological activity of curcumin reduces the severity of COVID-19. The results rank curcumin in the top five substances of 25 tested when used early to reduce illness and death from COVID.1
Turmeric is a perennial plant in the ginger family and found native to southern India and Indonesia.2 Like ginger, it is the underground rhizome that is used in cooking and for medicinal purposes. Traditionally, it was used in Ayurvedic medicine and traditional Chinese medicine.3
The cosmetic and fabric industry has also found uses for turmeric, having been used to dye fabric for more than 2,000 years.4 According to Linus Pauling Institute,5 evidence continues to mount showing that curcumin can exert antioxidant, anticancer, anti-inflammatory and neuroprotective activities.
Clinical trials are underway to evaluate the safety and efficacy of the compound as an adjuvant or as a treatment for patients with several types of cancer, including pancreatic, lung, prostate and colorectal cancers. The variety of positive health benefits found with curcumin may be a result of its highly pleiotropic capability, or ability of interacting with a variety of molecular targets.6
In the current environment, researchers have been studying anti-inflammatory compounds in an effort to reduce the severity of COVID-19. After multiple studies, curcumin outranks zinc, quercetin, melatonin and remdesivir, which ranked 24 out of the 25 substances.7
Current Curcumin Studies
The ranking was based on several studies performed in 2020 and 2021. In one study,8 researchers engaged 41 patients who met the inclusion criteria of mild to moderate COVID-19. There were 21 in the group who received nanocurcumin and 20 received a placebo.
The researchers monitored symptoms and laboratory data, finding that symptoms in the intervention group resolved significantly faster and patients’ oxygen saturation was higher after just two days of treatment. It remained higher than the control group through 14 days. Researchers also found it noteworthy that none of the patients who received the nanocurcumin deteriorated during the 14-day follow-up period, but 40% of the control group did.
A second study9 using nanocurcumin recruited 40 patients with COVID-19 to look at inflammatory cytokine expression. They were divided into 20 patients who received nanocurcumin and 20 who received a placebo. The researchers measured cytokine secretion of interleukin-1 beta (IL-1B), IL-6, tumor necrosis factor-alpha and IL-18. They concluded that the data demonstrated nanocurcumin modulates:
“… the increased rate of inflammatory cytokines especially IL-1β and IL-6 mRNA expression and cytokine secretion in COVID-19 patients, which may cause an improvement in clinical manifestation and overall recovery.”
Another study published in Frontiers in Pharmacology10 in early 2021 measured the differences in mortality between a control group and intervention group, each of which included 70 patients. The control and intervention groups received conventional COVID-19 treatment.
In addition, those in the intervention group received curcumin with piperine twice a day and those in the control group received probiotics twice a day. The researchers found patients who had mild, moderate and severe symptoms in the intervention group showed early symptomatic recovery and less deterioration.
Overall, they had better clinical outcomes and a lower death rate than the control group. Based on their results the researchers also concluded that curcumin may be a therapeutic option to prevent post COVID thromboembolic events.
Curcumin’s Action Is Similar to Proxalutamide
The drug in the No. 1 position for early treatment of COVID-19 is proxalutamide. It is an androgen receptor antagonist that was in clinical trials for the treatment of prostate cancer and breast cancer.11 At the start of the COVID-19 outbreak, the company found the drug could limit the expression of transmembrane protein serine 2 (TMPRSS2) and ACE-2 receptors, both which play a critical role in severity of COVID-19.
Ability of the virus to enter pneumocytes depends on TMPRSS2 that is expressed on the surface of human cells in much the same way as ACE-2.12 Interestingly, TMPRSS2 is regulated by an androgen receptor, which means that the ability of the virus to infect the cells is directly dependent on androgenic status.
Past research indicated that men who had androgenetic alopecia hair loss had a greater risk of severe disease and men taking antiandrogenic drugs had a reduced risk of severe disease. This led to the hypothesis that proxalutamide would be beneficial, as it is an androgen receptor antagonist.
The hypothesis was supported in a study13 that engaged 236 men and women with COVID-19. By Day 7, the virus was not detected using a PCR test with a cycle threshold of greater than 40 in 82% of the subjects taking proxalutamide. The average time it took patients to show clinical remission in the treatment group was 4.2 days versus 21.8 days in the placebo group.
In one study14 evaluating the ability of three polyphenols to suppress SARS-CoV-2 viral penetration into human cells, researchers found that curcumin treatments decreased the TMPRSS2 activity by up to 50%. This is similar to the mechanism demonstrated by proxalutamide in the recent studies.
Curcumin Alone Has Poor Bioavailability
Turmeric and curcumin have been challenging to study since curcumin has a low bioavailability when taken orally, which researchers attribute to the body’s limited ability to absorb the compound, as well as rapid metabolism and elimination.15 However, researchers have found there are different compounds, that when taken with curcumin, can raise bioavailability and therefore enhance the multiple health benefits attributed to curcumin.
For example, piperine is an alkaloid found in black pepper, which is responsible for the distinct taste. On its own, it has several health benefits, including anti-inflammatory effects and insulin resistance properties.16 When scientists combine it with curcumin it can raise the bioavailability of curcumin by up to 2,000%17 by blocking the metabolic pathway,18 thus increasing the amount available in the body.
One study published in the journal Medicine19 in 2021 addressed the issues of bioavailability of curcumin as it relates to conflicting dosing strategies and the ability to compare research data. The writers described clinical trials in which purified curcumin was given in relatively large doses, up to 12 grams per day, without achieving measurable plasma levels.20
In addition to combining curcumin with piperine to raise bioavailability, the writers acknowledge manipulating curcumin in other ways can also enhance bioavailability, such as reduced particle size, emulsions, essential oil complexes or the addition of whey protein or surfactants.
At the completion of one study, 17 healthy men between 18 years and 45 years participated in the double-blind, randomized crossover study.23 People who were using any products or food with turmeric within the 14 days before the study started were excluded. The researchers used several serum measurements to determine bioavailability, including the bioactive metabolite, tetrahydrocurcumin.
They found individuals taking curcumin had 39 times higher the amount of free curcumin, 31 times higher the amount of tetrahydrocurcumin, 49.5 times the amount of total curcumin and 52.5 times the amount of total curcuminoids over the compared standard curcumin reference product.24
Curcumin May Reduce Pain in Those With Arthritis
A 2019 report from the Arthritis Foundation25 found that there were 54.4 million people in the U.S. between 2013 and 2015 that had been diagnosed by their physician with arthritis. Conservatively, they estimate this number will increase 49% to 78.4 million people by 2040.
This represents 25.9% of all adults. Additionally, the number whose activities are limited due to their arthritis are estimated to jump from 43.5% of all people with the condition in 2015 to 52% by 2040. The condition is painful, and people often turn to anti-inflammatory and pain medications to relieve the discomfort.
The Arthritis Foundation26 lists topical and oral nonsteroidal anti-inflammatory drugs, steroid, hyaluronic acid, platelet rich plasma and stem cell injections as a means of reducing pain and thus potentially improving activity levels.
However, many of these treatments come with a list of side effects and are not always well tolerated. Since the safety and nontoxicity of curcumin, even at high doses, has been documented in human trials27 studies have evaluated whether the anti-inflammatory effects of curcumin could help those with osteoarthritis, which is the most common form of arthritis.28
One study29 engaged 139 people with knee osteoarthritis for a randomized, open-label, active controlled clinical study to receive either curcumin or diclofenac twice daily for 28 days. Baseline measurements were taken before the interventions began and then again at Days 7, 14 and 28.
The main outcome measure was pain. Researchers also had secondary outcome measures that included anti-ulcer effect, anti-flatulent effect, altered weight and a global assessment of therapy. By Days 14 and 28, there was no statistically significant difference between those taking curcumin and those taking diclofenac in pain measurements.
Those taking curcumin had fewer episodes of flatulence and by Day 28, had a statistically significant weight loss and anti-ulcer effect. No patient using curcumin required an H2 blocker, while 28% of those using diclofenac needed an H2 blocker to reduce excess stomach acid. Researchers found that curcumin had a similar effect in reducing pain to diclofenac but was better tolerated and had fewer side effects.
Additional Health Benefits for Curcumin
Natural plants have been used for medicinal purposes throughout history, and turmeric is not an exception. There is evidence it was used in human health as far back as 4,000 years ago and modern medicine has seen over 3,000 papers published on it within the last 25 years.30
In addition to pain relief, curcumin has also demonstrated the ability to make significant changes in cognitive function and mood in older adults who took the supplement for at least four weeks.31 Researchers found significant improvement in working memory, general fatigue and state of calmness. Additionally, it significantly reduced total and LDL cholesterol.
A second study32 performed at the University of California Los Angeles and published in the American Journal of Geriatric Psychiatry examined the effects of curcumin on individuals who had no history of dementia. The study’s first author, Dr. Gary Small, said in a press release:33
“Exactly how curcumin exerts its effects is not certain, but it may be due to its ability to reduce brain inflammation, which has been linked to both Alzheimer’s disease and major depression.”
The study followed 40 people between ages 50 and 90 who had mild memory complaints. Researchers found those who took the curcumin had significant improvements in memory and attention abilities, as well as mild improvement in mood and significantly fewer amyloid and tau signals in the amygdala and hypothalamus, areas of the brain that control some memory and emotional functions.34
One paper published in 201935 postulated that since chronic inflammation plays such a significant part in obesity, cardiovascular diseases and impaired glucose tolerance, increasing the bioavailability of curcumin may help modulate many of these lifestyle-related diseases.
A meta-analysis of three studies36 that included 326 patients, also found that curcumin has a beneficial effect on irritable bowel syndrome symptoms, and another analysis showed curcumin a being effective and well-tolerated agent for the treatment of some skin diseases.37
Researchers continue to evaluate the effects curcumin has on many conditions driven by chronic inflammation, including rheumatoid arthritis, ulcerative colitis, cognitive decline, major depressive disorders and premenstrual syndrome.38
Although curcumin is generally recognized as safe (GRAS),39 it has been found to increase the risk of bleeding in people taking medications that affect platelet aggregation, such as Lovenox, heparin or warfarin. People who are on chemotherapy should consult with their physician before including curcumin as it has inhibited chemotherapy-induced apoptosis in the lab.40
Additionally, curcumin may interfere with the metabolism of some drugs used in the U.S. and piperine, sometimes included with curcumin to increase bioavailability, may also affect the elimination and bioavailability of certain drugs.
Sources and References
- 1, 7 COVID-19 Early Treatment
- 2 Britannica, Turmeric
- 3 National Center for Complementary and Integrative Health, Turmeric
- 4 Cellular and Molecular Life Science, 2008;65(11):1631 History and Traditional Uses of Curcumin
- 5, 38, 40 Linus Pauling Institute, Curcumin
- 6 Alternative Medicine Review, 2009;14(2)
- 8 Phytotherapy Research, 2021;35(5)
- 9 International Immunopharmacology, 2020;89(B)
- 10 Frontiers in Pharmacology, 2021; doi.org/10.3389/fphar.2021.669362
- 11 PRNewswire, December 11, 2020
- 12, 13 Cureus, 2021;13(2)
- 14 PLOS|One, 2021; doi.org/10.1371/journal.pone.0253489
- 15, 17 Foods, 2017;6(10)
- 16 Advances in Experimental Medicine and Biology, 2016;928:173
- 18 Planta Medica, 1998;64(4)
- 19, 20, 21, 23, 24 Medicine, 2021; 10(27)
- 22 Pharmaceutics, 2018;10(3)
- 25 Arthritis Foundation, Arthritis By the Numbers
- 26 Arthritis Foundation, Comparing Pain Medications for Osteoarthritis
- 27 AAPS Journal, 2013;15(1)
- 28 Centers for Disease Control and Prevention, Osteoarthritis
- 29 Trials, 2019;20(214)
- 30 Herbal Medicine: Biomolecular and Clinical Aspects
- 31 Journal of Psychopharmacology, 2015;29(5)
- 32 The American Journal of Geriatric Psychiatry, 2018;26(3)
- 33, 34 UCLA Newsroom, January 22, 2018
- 35 European Cardiology Review, 2019;14(2)
- 36 Journal of Clinical Medicine, 2018;7(10)
- 37 Nutrients, 2019;11(9)
- 39 US Food and Drug Administration, June 4, 2019
Share this:
Related
September 13, 2021 - Posted by aletho | Science and Pseudo-Science, Timeless or most popular | Covid-19
No comments yet.
This site uses Akismet to reduce spam. Learn how your comment data is processed.
Featured Video
Russian education minister slams ‘terrible’ Eurovision
or go to
Aletho News Archives – Video-Images
From the Archives
Why Slovak Wildcard Robert Fico Could Bring EU House of Cards Crashing Down
By Ilya Tsukanov – Sputnik – 21.03.2024
Slovak Prime Minister Robert Fico has found himself in the crosshairs of Eurocrats worried that he may become the next Viktor Orban -a thorn in Brussels’ backside rejecting EU directives on everything from Ukraine to criminal justice reform. Sputnik asked Slovak politician Peter Marcek what it is about Fico that’s so unnerving to the establishment. … continue
Blog Roll
-
Join 2,755 other subscribers
Visits Since December 2009
- 6,736,359 hits
Looking for something?
Archives
Calendar
Categories
Aletho News Civil Liberties Corruption Deception Economics Environmentalism Ethnic Cleansing, Racism, Zionism Fake News False Flag Terrorism Full Spectrum Dominance Illegal Occupation Mainstream Media, Warmongering Malthusian Ideology, Phony Scarcity Militarism Progressive Hypocrite Russophobia Science and Pseudo-Science Solidarity and Activism Subjugation - Torture Supremacism, Social Darwinism Timeless or most popular Video War Crimes Wars for IsraelTags
9/11 Afghanistan Africa al-Qaeda Australia BBC Benjamin Netanyahu Brazil Canada CDC Central Intelligence Agency China CIA CNN Colombia Covid-19 COVID-19 Vaccine Da’esh Donald Trump Egypt European Union Facebook FBI FDA France Gaza Germany Google Hamas Hebron Hezbollah Hillary Clinton Human rights India Iran Iraq ISIS Israel Israeli settlement Japan Jerusalem Joe Biden Korea Latin America Lebanon Libya Middle East National Security Agency NATO New York Times North Korea NSA Obama Pakistan Palestine Qatar Russia Sanctions against Iran Saudi Arabia Syria The Guardian Turkey Twitter UAE UK Ukraine United Nations United States USA Venezuela Washington Post West Bank WHO Yemen ZionismRecent Comments
Aletho News
- UK Disinformation Unit Minutes Reveal Consideration of Placing Government Employees Inside Social Media Companies
- Australia jails whistleblowers for telling the truth
- British Palestinian surgeon wins legal battle against Germany’s travel ban
- Israeli troops lament return to north Gaza months after ‘dismantling’ Hamas
- Harvard agrees to discuss divestment from ‘Israel’ following protests
- Orbán: We have enough warmongers in the EU parliament, don’t send more
- Ukraine Prepares Total Mobilization in 5 Controlled Cities – Russian Official
- Ukraine desperate to receive more Western aid
- Meta’s Oversight Board Adopts International “Norms” Instead of US Free Speech Principles
- RFK Jr. Files Lawsuit Against Meta, Alleging Censorship of Presidential Campaign Video
If Americans Knew
- On Nakba Day, as Palestinians run for their lives, Biden advances $1 billion in arms sales to Israel – Day 221
- New! English translation of eyewitness Red Cross account of 1948 Deir Yassin massacre
- Knowledge is going up in smoke in Gaza
- Israeli settlers destroy truckloads of aid, as Israeli forces watch, Gazans starve – Day 220
- Who’s Funding AIPAC’s Political Spending Barrage?
- For Columbia and a Powerful Donor, Months of Talks and Millions at Risk
- Columbia crackdown led by university prof doubling as NYPD spook
- Disaster unfolds all over Gaza, West Bank – Day 219
- Israeli airstrikes in southern Gaza, invasion in central Gaza, carpet bombing in north – Day 218
- Strapped down, blindfolded, held in diapers: Israeli whistleblowers detail abuse of Palestinians in shadowy detention center
Richie Allen
- The Richie Allen Show Returns Tomorrow Wednesday April 24th
- Call Richie Today Monday March 11th From 4.30pm
- Connect To The Richie Allen Show WhatsApp Today
- NHS Asks Patients To Choose From 12 Genders, 10 sexual Preferences & 159 Religions
- The Richie Allen Show Moves To A New Time Slot From Monday Nov 20th
- Starmer Will Sack Shadow Ministers Who Vote For Gaza Ceasefire
- AI Tool Can Predict Heart Attacks Years In Advance
- Nepal Bans TikTok To Preserve Social Harmony
- Bloke Appointed Boss Of Womb Health Charity
- WHO – “Gaza’s Biggest Hospital Becoming A Cemetery”
No Tricks Zone
- U.N. Contributing Scientist: ‘Culling’ Human Population Could Avert Climate Catastrophe
- Using Nets On The Seafloor To Retrieve Seafood ‘Roughly The Same As Running 100 Coal-Fired Plants’
- New Paper: Global Warming Leading To HIMALAYAN COOLING, Preventing Glacial Melt!
- DNA Evidence Reveals Domestic Cats, Dogs, African Wildcats, Frogs Lived In The Arctic 9000 Years Ago
- -80°C: Antarctic Vostok Station Records “Extreme Winter Cold”…Not Even Winter Yet!
- The German E-Vehicle Nightmare, 2024 Q1 Sales Plummet 14%… “Graveyard” For Unsold Cars
- Newly Discovered 90,000-Year-Old Human Footprints Reveal How Much Higher Sea Levels Used To Be
- Germany’s Economic Bloodbath Worsens As Green Revolution Causes Economy To Bleed To Death
- Water Vapor Absorbs 84 Times More Radiation Than CO2 … Clouds Drove 89% Of 1982-2018 Warming
- The 97% Consensus Claim Is In Fact 97% Bogus
More Links
Contact:
atheonews (at) gmail.com
Disclaimer
This site is provided as a research and reference tool. Although we make every reasonable effort to ensure that the information and data provided at this site are useful, accurate, and current, we cannot guarantee that the information and data provided here will be error-free. By using this site, you assume all responsibility for and risk arising from your use of and reliance upon the contents of this site.
This site and the information available through it do not, and are not intended to constitute legal advice. Should you require legal advice, you should consult your own attorney.
Nothing within this site or linked to by this site constitutes investment advice or medical advice.
Materials accessible from or added to this site by third parties, such as comments posted, are strictly the responsibility of the third party who added such materials or made them accessible and we neither endorse nor undertake to control, monitor, edit or assume responsibility for any such third-party material.
The posting of stories, commentaries, reports, documents and links (embedded or otherwise) on this site does not in any way, shape or form, implied or otherwise, necessarily express or suggest endorsement or support of any of such posted material or parts therein.
The word “alleged” is deemed to occur before the word “fraud.” Since the rule of law still applies. To peasants, at least.
Fair Use
This site contains copyrighted material the use of which has not always been specifically authorized by the copyright owner. We are making such material available in our efforts to advance understanding of environmental, political, human rights, economic, democracy, scientific, and social justice issues, etc. We believe this constitutes a ‘fair use’ of any such copyrighted material as provided for in section 107 of the US Copyright Law. In accordance with Title 17 U.S.C. Section 107, the material on this site is distributed without profit to those who have expressed a prior interest in receiving the included information for research and educational purposes. For more info go to: http://www.law.cornell.edu/uscode/17/107.shtml. If you wish to use copyrighted material from this site for purposes of your own that go beyond ‘fair use’, you must obtain permission from the copyright owner.
DMCA Contact
This is information for anyone that wishes to challenge our “fair use” of copyrighted material.
If you are a legal copyright holder or a designated agent for such and you believe that content residing on or accessible through our website infringes a copyright and falls outside the boundaries of “Fair Use”, please send a notice of infringement by contacting atheonews@gmail.com.
We will respond and take necessary action immediately.
If notice is given of an alleged copyright violation we will act expeditiously to remove or disable access to the material(s) in question.
All 3rd party material posted on this website is copyright the respective owners / authors. Aletho News makes no claim of copyright on such material.
Leave a comment